Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang

International Immunopharmacology

Volumn 3, Issue 2, 2003, Pages 147-157

  Lee, Soo Jin ^a,b   Saiki, Ikuo ^a   Hayakawa, Yoshihiro ^a   Nunome, Shinyu ^c   Yamada, Haruki ^c   Kim, Sung Hoon ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Kyung Hee University   (South Korea)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Cytokines; Helper T cell; Macrophages; Traditional herbal prescription; Tumor metastasis

Indexed keywords

AGARICUS BLAZEI EXTRACT; ANGELICA GIGAS EXTRACT; ANTINEOPLASTIC AGENT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES EXTRACT; BOJUNG BANGAM TANG; CITRUS UNSHIU EXTRACT; CONCANAVALIN A; DIOSCOREA JAPONICA EXTRACT; GAMMA INTERFERON; GINSENG EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 4; NAKAI EXTRACT; PLANT EXTRACT; POLYPOURS EXTRACT; UNCLASSIFIED DRUG;

AGARICUS BLAZEI; ANGELICA GIGAS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; ATRACTYLODES; CANCER INHIBITION; CANCER PREVENTION; CELL MEDIATED CYTOTOXICITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIOSCOREA NIPPONICA; DOSE LIVER FUNCTION RELATION; DRUG MECHANISM; FEMALE; GINSENG; GLYCYRRHIZA URALENSIS; INOCULATION; LIVER METASTASIS; MACROPHAGE ACTIVATION; MEDICINAL PLANT; METASTASIS INHIBITION; MITOGENESIS; MITOGENICITY; MOUSE; NAKAI; NATURAL KILLER CELL; NONHUMAN; POLYPOURS UMBELLATUS; PRIORITY JOURNAL; SATSUMA; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0037315913     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00091-7     Document Type: Article

References (42)

1. Minagawa M., Makuuchi M., Torzilli G., Takayama T., Kawasaki S.et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann. Surg. 231:2000;487-499.
2. Bosman F.T. Prognostic value of pathological characteristics of colorectal cancer. Eur. J. Cancer. 31A:1995;1216-1221.
3. Ohnishi Y., Fujii H., Hayakawa Y., Sakukawa R., Yamaura T.et al. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Jpn. J. Cancer Res. 89:1998;206-213.
4. Corbett T.H., Griswold D.P. Jr., Roberts B.J., Peckham J.C.et al. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35:1975;2434-2439.
5. Ohnishi Y., Sakamoto T., Fujii H., Kimura F., Murata J.et al. Characterization of a liver metastatic variant of murine colon 26 carcinoma cells. Tumor Biol. 18:1997;113-122.
6. Fidler IJ, Selection of successive tumour lines for metastasis. Nature New Biol. 242:148-149.
7. Ohnishi Y., Fujii H., Murakami K., Sakamoto T., Tsukada K.et al. A new pseudo-peptide analogue of Arg-Gly-Asp (RGD) sequence inhibits liver metastasis of colon 26-L5 carcinoma cells. Cancer Lett. 124:1998;157-163.
8. Sorimachi K., Akimoto K., Ikehara Y., Inafuku K., Okubo A.et al. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct. Funct. 26:2001;103-108.
9. Saiki I. A Kampo medicine "Juzen-taiho-to"-prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biol. Pharm. Bull. 23:2000;677-688.
10. Harada M., Seta K., Ito O., Tamada K., Li T.et al. Concomitant immunity against tumor development is enhanced by the oral administration of a Kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol. Immunotoxicol. 17:1995;687-703.
11. Suda K., Murakami K., Murata J., Hasegawa H., Saiki I. An intestinal bacterial metabolite (M1) of ginseng protopanaxadiol saponins inhibits tumor-induced neovascularization. J. Trad. Med. 17:2000;144-150.
12. Song B.K. New summarized prescriptions and their indications. 1985;500-503 Dongwon Press.
13. Fujimiya Y., Suzuki Y., Oshiman K., Kobori H., Moriguchi K.et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus Blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol. Immunother. 46:1998;147-159.
14. Mizuno M., Morimoto M., Minato K., Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci. Biotechnol. Biochem. 62:1998;434-437.
15. Wang H.X., Ng T.B., Ooi V.E., Liu W.K., Chang S.T. A polysaccharide-peptide complex from cultured mycelia of the mushroom Tricholoma mongolicum with immunoenhancing and antitumor activities. Biochem. Cell. Biol. 74:1996;95-100.
16. Takaku T., Kimura Y., Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J. Nutr. 131:2001;1409-1413.
17. Sorimachi K., Ikehara Y., Maezato G., Okubo A., Yamazaki S.et al. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci. Biotechnol. Biochem. 65:2001;1645-1647.
18. Ohno N., Furukawa M., Miura N.N., Adachi Y., Motoi M.et al. Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol. Pharm. Bull. 24:2001;820-828.
19. Wu J., Gardner B.H., Murphy C.I., Seals J.R., Kensil C.R.et al. Saponin adjuvant ehhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 148:1992;1519-1525.
20. Lee S., Sung J., Lee S., Moon C., Lee B. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett. 144:1999;39-43.
21. Sato K., Mochizuki M., Saiki I., Yoo Y., Samukawa K.et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, Ginsenoside-Rb2. Biol. Pharm. Bull. 17:1994;635-639.
22. Saiki I., Yamaura T., Ohnishi Y., Hayakawa Y., Komatsu Y.et al. HPLC analysis of Juizen-taiho-to and its variant formulations and their antimetastatic efficacies. Chem. Pharm. Bull. 47:1999;1170-1174.
23. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
24. Brunda M.J., Luistro L., Warrier R.R., Wright R.B., Hubbard B.R.et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1993;1223-1230.
25. Tau G., Rothman P. Biologic functions of the IFN-gamma receptors. Allergy. 54:1999;1233-1251.
26. Hayakawa Y., Fujii H., Hase K., Ohnishi Y., Sakukawa R.et al. Anti-metastatic and immunomodulating properties of the water extract from Celosia argentea seeds. Biol. Pharm. Bull. 21:1998;1154-1159.
27. Kasai M., Iwamori M., Nagai Y., Okumura K., Tada T. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:1980;175-180.
28. Habu S., Fukui H., Shimamura K., Kasai M., Nagai Y.et al. In vivo effects of anti-asialo GM1: I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127:1981;34-38.
29. Saito T., Yamaguchi J. 2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism. J. Immunol. 134:1985;1815-1822.
30. Mu J., Zou J., Yamamoto N., Tsutsui T., Tai X.et al. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55:1995;4404-4408.
31. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263-266.
32. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today. 21:2000;479-483.
33. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M.et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:1991;3074-3081.
34. Rossi A.R., Pericle F., Rashleigh S., Janiec J., Djeu J.Y. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood. 83:1994;1323-1328.
35. Nastala C.L., Edington H.D., McKinney T.G., Tahara H., Nalesnik M.A.et al. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1994;1697-1706.
36. Fidler I.J. Macrophages and metastasis-a biological approach to cancer therapy: presidential address. Cancer Res. 45:1985;4714-4726.
37. Hanna N. Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev. 1:1982;45-64.
38. Tsung K., Meko J.B., Peplinski G.R., Tsung Y.L., Norton J.A. IL-12 induces T helper 1-directed antitumor response. J. Immunol. 158:1997;3359-3365.
39. + αβ T cells activated by IL-12 as a major effector inhibition of experimental tumor metastasis. J. Immunol. 156:1996;3366-3373.
40. Wu C., Demeure C., Kiniwa M., Gately M., Delespesse G. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J. Immunol. 151:1993;1938-1949.
41. Street N.E., Schumacher J.H., Fong T.A.T., Bass H., Fiorentino D.F.et al. Hetrogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144:1993;1629-1639.
42. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.